2022 American Transplant Congress » Liver: Hepatocellular Carcinoma and Other Malignancies
Date: Sunday, June 5, 2022
Time: 7:00pm-8:00pm
Location: Hynes Halls C & D
Session Type: Poster Abstract
Meeting: 2022 American Transplant Congress
- 7:00pm-8:00pm
A Intention-to-Treat Analysis of 881 Consecutively Waitlisted Patients to Develop a Survival Benefit Model for Hepatocellular Carcinoma Liver Transplant Candidates
B. V. Tran1, W. Lapisatepun1, W. Dumronggittigule1, D. Markovic2, Y. Lee1, F. Kaldas1, D. Farmer1, R. Busuttil1, V. Agopian1
- 7:00pm-8:00pm
An International Multi-Institutional Comparison of Liver Transplantation for Hepatocellular Carcinoma: United States, United Kingdom, and Canada
T. Ivanics1, D. Wallace2, M. P. Claasen3, M. Patel4, W. Jassem5, K. Menon5, A. Suddle5, N. Heaton5, N. Mehta6, J. van der Meulen2, G. Sapisochin3
- 7:00pm-8:00pm
Characterizing Outcomes of Patients with Colorectal Liver Metastases (CRLM) Undergoing Liver Transplantation (LT) Evaluation
E. Takoushian1, E. Brandon1, B. Samstein2, K. Halazun2
- 7:00pm-8:00pm
Everolimus in Liver Transplantation for Diffuse, Unresectable Neuroendocrine Tumor
J. M. Vanatta1, R. A. Helmick2, C. Eymard2, N. Nezakatgoo2, P. Horton2, J. P. Kothadia2, S. P. Nair2, J. D. Eason2
- 7:00pm-8:00pm
Exploring Individual Optimal Immunosuppression Management According to the Oncological Risk in Liver Transplanted Patients with Hepatocellular Carcinoma
K. Sasakik1, S. Kimura2, D. Soma3, K. Tomiyama4, M. Matthew4, M. Fruscione2, C. Kubal3, D. Kwon5
- 7:00pm-8:00pm
Higher Hepatocellular Carcinoma Tumor Burden Score is Associated with Grater Liver Transplant Survival Benefit
H. Liu1, W. Zhang2, M. Di3, H. Lee4, R. Cruz1, X. Wang2, C. Kaltenmeier1, A. Thompson1, D. Reddy1, E. Ashwat1, M. D'Alesio1, S. Lebowitz1, S. Tohme1, D. Geller1, A. Tevar1, C. Hughes1, A. Humar1, J. Behari5, R. Bataller5, S. Hariharan5, M. Molinari1
- 7:00pm-8:00pm
Immune Checkpoints, Immune Cells, and MHC Expression in the Tumor Microenvironment of Resected Hepatocellular Carcinomas
A. Baquerizo1, V. Vavinskaya2, S. Bagsic1, A. Rojas3, A. Mhoyan4, C. Frenette1, L. Sher5, M. Romero3, J. Fisher1, C. Marsch1, R. Schaffer1
- 7:00pm-8:00pm
Impacts Of Donor Gender On Recurrent Hepatocellular Carcinoma In Liver Transplant Donated After Brain Death
T. Nakamura1, K. Sasaki2, T. Yamamoto1, S. Kimura1, L. Dageforde1, H. Yeh1, N. Elias1, T. Kawai1, J. F. Markmann1
- 7:00pm-8:00pm
Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: An Analysis of the European Liver Transplant Registry
M. P. Claasen1, T. Ivanics2, J. N. IJzermans1, G. Sapisochin2, W. Polak1
- 7:00pm-8:00pm
Liver Transplantation for Patients with Fibrolamellar Hepatocellular Carcinoma: A Comprehensive Multicenter Analysis to Support Future Decision Making
M. P. Claasen1, T. Ivanics1, W. G. Polak2, J. N. IJzermans2, G. Sapisochin1
- 7:00pm-8:00pm
Locoregional Therapy and Long-Term Post-Transplant Outcomes for HCC Liver Transplant Recipients
T. Ishaque, S. R. Weeks, A. Kolarich, J. Ruck, J. Garonzik-Wang, D. Segev, A. Massie, B. King
- 7:00pm-8:00pm
Locoregional Therapy for Hepatocellular Carcinoma Decreases Liver Transplant Waitlist Dropout and Mortality
S. Weeks, T. Ishaque, A. Massie, D. Segev, E. King
- 7:00pm-8:00pm
Nivolumab After Sorafenib Failure in Liver Recipients with HCC Recurrence
J. Kwon
- 7:00pm-8:00pm
Outcomes of ABO-Incompatible Adult Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria
B. Lee, J. Cho, H. Lee
- 7:00pm-8:00pm
The Impact of Yttium-90 Radioembolization on T Cell Phenotypes in Bridged to Transplant Hepatocellular Carcinoma Patients
K. Nunez, T. Sandow, P. Thevenot, A. Cohen
- 7:00pm-8:00pm
The Oncological Influences of Pre- and Post-Transplant Sustained Viral Response in Liver Transplant for Hepatocellular Carcinoma
K. Sasaki1, S. Kimura2, K. Tomiyama3, Y. Bekki4, M. Murray3, P. Huang3, M. Fruscione2, A. Moro5, C. Kwon6
- 7:00pm-8:00pm
Tumor Suppressor Role of the Caveolar α1-na/k-atpase Signalosome in Nash Related Hepatocellular Carcinoma (HCC)
U. Udoh1, M. Banerjee1, J. D. Sanabria1, P. K. Rajan1, M. Schade2, J. A. Sanabria3, S. Pierre3, J. R. Sanabria4
« View all sessions from the 2022 American Transplant Congress